U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2913129131Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Telmisartan/Amlodipine|Drug: Telmisartan/Amlodipine/HCTZ|Drug: Telmisartan/HCTZhttps://ClinicalTrials.gov/show/NCT02183675
2913229132Safety and Pharmacokinetics of Single Rising Oral Doses of BI 224436 ZW in Healthy Male Volunteers.CompletedNo Results AvailableHealthyDrug: BI 224436|Drug: Placebo to BI 224436https://ClinicalTrials.gov/show/NCT02183662
2913329133Tolerability and Potential ECG Effects After a Single Oral Dose of Pentoxyverine Citrate in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: pentoxyverine citrate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183649
2913429134Relative Bioavailability of Two Fixed Dose Combination Tablets of Linagliptin/Pioglitazone Compared With Single Linagliptin and Pioglitazone Tablets Administered Together to Healthy Male and Female SubjectsCompletedNo Results AvailableHealthyDrug: Linagliptin/pioglitazone, FDC formulation C5|Drug: Linagliptin/pioglitazone, FDC formulation C8|Drug: Linagliptin tablet|Drug: pioglitazone tablet (Actos®)https://ClinicalTrials.gov/show/NCT02183636
2913529135The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Simvastatin|Drug: 10 mg BI 1356 BShttps://ClinicalTrials.gov/show/NCT02183623
2913629136Investigation of the Metabolism and Pharmacokinetics of 10 mg [14C] BI 1356 Administered Orally Compared to 5 mg [14C] BI 1356 Administered Intravenously in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: [14C] BI 1356 as oral (p.o.) solution|Drug: [14C] BI 1356 solution for i.v. infusionhttps://ClinicalTrials.gov/show/NCT02183610
2913729137Whole-body MRI for the Detection of MetastasisNot yet recruitingNo Results AvailableBreast Cancer|Metastaseshttps://ClinicalTrials.gov/show/NCT02183597
2913829138Study to Evaluate the Effect of Multiple Doses of Rifampicin on the Multiple-dose Pharmacokinetics of Linagliptin in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Rifampicin|Drug: Linagliptinhttps://ClinicalTrials.gov/show/NCT02183584
2913929139Bioequivalence Study of Two Strengths of Two Different Metformin Tablets Administered to Healthy Male and Female SubjectsCompletedNo Results AvailableHealthyDrug: Merck Glucophage® high dose|Drug: BMS Glucophage® high dose|Drug: Merck Glucophage® low dose|Drug: BMS Glucophage® low dosehttps://ClinicalTrials.gov/show/NCT02183571
2914029140Screening for GDM in Women With PCOS and ControlsCompletedNo Results AvailablePolycystic Ovary Syndrome|Gestational Diabetes MellitusOther: OGTT by randomization|Other: OGTT by indicationhttps://ClinicalTrials.gov/show/NCT02183558
2914129141Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1060469 in Healthy Asian Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1060469|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183545
2914229142Pharmacokinetics of Single and Multiple Oral Doses of BI 1356 in Healthy Chinese VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356 BS|Drug: BI 1356 BShttps://ClinicalTrials.gov/show/NCT02183532
2914329143Respiratory Kinematics of Cough in Healthy Older Adults and Parkinson's DiseaseCompletedNo Results AvailableCough|Parkinson's DiseaseDrug: Capsaicin|Other: Healthy Older Adults|Other: Parkinson's Diseasehttps://ClinicalTrials.gov/show/NCT02183519
2914429144Bioavailability of BI 1356 BS and Metformin After Co-administration Compared to the Bioavailability of BI 1356 BS Alone and Metformin Alone in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Metformin|Drug: BI 1356 BShttps://ClinicalTrials.gov/show/NCT02183506
2914529145Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female SubjectsCompletedNo Results AvailableHealthyDrug: BI 1356https://ClinicalTrials.gov/show/NCT02183493
2914629146Dose Proportionality of Different Dose Strengths of Linagliptin Tablets After Oral Administration to Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: Linagliptin, low dose|Drug: Linagliptin, medium dose|Drug: Linagliptin, high dosehttps://ClinicalTrials.gov/show/NCT02183480
2914729147Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male SubjectsCompletedNo Results AvailableHealthyDrug: BI 1356, low dose|Drug: BI 1356, high dose|Drug: Placebo|Drug: Moxifloxacinhttps://ClinicalTrials.gov/show/NCT02183467
2914829148MASCOT - Post Marketing RegistryRecruitingNo Results AvailableCoronary Artery Disease|AtherosclerosisDevice: OrbusNeich COMBO stenthttps://ClinicalTrials.gov/show/NCT02183454
2914929149Bioavailability of BI 1356 After Co-administration With Ritonavir Compared to the Bioavailability of BI 1356 Alone in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356|Drug: Ritonavirhttps://ClinicalTrials.gov/show/NCT02183441
2915029150Bioavailability of BI 1356 and Glyburide in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356|Drug: Glyburide|Drug: BI 1356 + Glyburidehttps://ClinicalTrials.gov/show/NCT02183428
2915129151Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS as Tablet in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: BI 1356 BS, low dose|Drug: BI 1356 BS, medium dose|Drug: BI 1356 BS, high dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183415
2915229152Pharmacokinetics, Safety and Tolerability of Digoxin With or Without Co-administration of BI 1356 in Healthy VolunteersCompletedNo Results AvailableHealthyDrug: Digoxin|Drug: BI 1356https://ClinicalTrials.gov/show/NCT02183402
2915329153Bioavailability of Warfarin After Coadministration With Multiple Doses of BI 1356 Compared to the Bioavailability of Warfarin Alone in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: Warfarin|Drug: BI 1356https://ClinicalTrials.gov/show/NCT02183389
2915429154Pharmacokinetics and Pharmacodynamics of BI 1356 in Subjects With Different Degrees of Liver Impairment as Compared to Healthy SubjectsCompletedNo Results AvailableHepatic InsufficiencyDrug: BI 1356https://ClinicalTrials.gov/show/NCT02183376
2915529155Bioavailability of BI 1356 After Single Oral Administration Given as Different Tablet Formulation in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356 - Tablet TFII|Drug: BI 1356 - Tablet iFF|Drug: BI 1356 - Tablet TFIIbhttps://ClinicalTrials.gov/show/NCT02183363
2915629156Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1356 BS in Patients With Type 2 DiabetesCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: BI 1356 BS - single rising dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183350
2915729157Bioavailability of BI 1356 With and Without Co-administration of Pioglitazone and the Bioavailability of Pioglitazone With and Without Coadministration of BI 1356 in Healthy Male and Female VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356|Drug: BI 1356 + Pioglitazone|Drug: Pioglitazonehttps://ClinicalTrials.gov/show/NCT02183337
2915829158BI 1356 BS in Japanese Patients With Type 2 Diabetes MellitusCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Low dose of BI 1356 BS|Drug: Medium dose of BI 1356 BS|Drug: High dose of BI 1356 BS|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183324
2915929159Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising Oral Doses and Multiple Rising Oral Doses of BI 1356 BS in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356 BS - single rising dose|Drug: BI 1356 BS - multiple rising dose|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183311
2916029160Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Doses of BI 1356 BS in Healthy Male VolunteersCompletedNo Results AvailableHealthyDrug: BI 1356 BS - intravenous|Drug: BI 1356 BS - Tablet|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02183298

* Görseller ve İçerik tekif hakkına sahip olabilir